Adaptimmune Therapeutics PLC (ADAPY) stock
ADAPYOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2025, quý kết thúc ngày Jun 30, 2025Last filing: 10-Q on Aug 13, 2025Score 3/30
$0.04+0.00 (+9.38%)
Close on Oct 19, 2026Market cap $55.46MP/E –Yield –
Adaptimmune Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Adaptimmune Therapeutics's price to book ratio was 35.9× on Apr 30, 2025, against 41.0× a year earlier. Over the last 5 years it ranged from 5.8× to 83.6×, with a median of 14.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Apr 30, 2025 | 35.9× | +25.6 |
| 2024 | Dec 31, 2024 | 10.3× | −1.9 |
| 2023 | Dec 29, 2023 | 12.3× | −0.4 |
| 2022 | Dec 30, 2022 | 12.7× | −1.9 |
| 2021 | Dec 31, 2021 | 14.6× | +1.3 |
| 2020 | Dec 31, 2020 | 13.3× | +8.2 |
| 2019 | Dec 31, 2019 | 5.1× | −30.1 |
| 2018 | Apr 30, 2018 | 35.2× | +18.8 |
| 2017 | Dec 29, 2017 | 16.4× | +9.8 |
| 2016 | Dec 30, 2016 | 6.6× | −13.1 |
| 2015 | Dec 31, 2015 | 19.8× | – |
See a number that looks wrong?